Bealmear Richard Craig 4
4 · Oklo Inc. · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
Oklo (OKLO) CFO Richard Bealmear Sells Shares After Exercising Options
What Happened
Richard Craig Bealmear, Chief Financial Officer of Oklo, exercised stock options and sold a portion of the resulting shares. On May 1, 2026 he exercised 16,216 options at $3.18 each (cost $51,567) and sold those 16,216 shares in the open market under a Rule 10b5-1 plan for a weighted average price of $69.92, generating proceeds of about $1,133,823. On May 4, 2026 he exercised an additional 5,880 options at $3.18 each (cost $18,698). The filing also shows the underlying option instruments were surrendered (derivative dispositions at $0.00) as part of the exercises. In total he exercised 22,096 options for a combined exercise cost of about $70,265; 16,216 of the resulting shares were sold and 5,880 appear to have been retained.
Key Details
- Transaction dates: May 1, 2026 (exercise + sale) and May 4, 2026 (exercise).
- Exercise price: $3.18 per share. Total exercised shares: 22,096; total exercise cost ≈ $70,265.
- Sale: 16,216 shares sold on May 1, 2026 at a weighted average price of $69.92 (range $69.89–$70.09), proceeds ≈ $1,133,823. (F2, F3)
- Derivative entries: The filing shows the related options were disposed at $0.00, reflecting surrender/cancellation of the exercised options.
- Plan/footnotes: Sales were effected under a Rule 10b5-1 trading plan adopted Sept 22, 2025 (F2). Vesting schedule for the option grant noted (20% vested Aug 1, 2024; then monthly vesting) (F4). For total holdings, see the issuer’s latest proxy as referenced in the filing (F1).
- Timeliness: Form 4 filed May 5, 2026 for transactions on May 1 and May 4; filing meets the standard two-business-day deadline.
Context: This was an option exercise followed by an immediate market sale of most of the shares — effectively a partial cashless exercise where proceeds from the sale cover the exercise cost and generate net proceeds. The 10b5-1 plan indicates the sale was preplanned; retained shares (5,880) may remain subject to company holding and vesting terms. This is a routine insider liquidity event and should not be taken alone as a signal of company fundamentals.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-05-01$3.18/sh+16,216$51,567→ 407,978 total - Sale
Class A Common Stock
[F2][F3][F1]2026-05-01$69.92/sh−16,216$1,133,823→ 391,762 total - Exercise/Conversion
Class A Common Stock
[F1]2026-05-04$3.18/sh+5,880$18,698→ 397,642 total - Exercise/Conversion
Stock Options
[F4]2026-05-01−16,216→ 808,283 totalExercise: $3.18Exp: 2033-12-22→ Class A Common Stock (16,216 underlying) - Exercise/Conversion
Stock Options
[F4]2026-05-04−5,880→ 802,403 totalExercise: $3.18Exp: 2033-12-22→ Class A Common Stock (5,880 underlying)
Footnotes (4)
- [F1]For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- [F2]The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted on September 22, 2025.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.89- $70.09 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The stock option vested as to 20% of the underlying shares on August 1, 2024 and continues to vest thereafter in 48 substantially equal monthly installments.